Japan Clears Extraction Catheter Distributed By Nihon Kohden
This article was originally published in PharmAsia News
Japanese regulators have cleared Nihon Kohden's extraction catheter for marketing. The Pronto V3 is made by Vascular Solutions of the United States, but distributed in Japan by Nihon. The companies expect the catheter to launch in Japan as early as the third quarter. The device is designed to provide aspiration removal of acute thrombus from the arterial system. (Click here for more
You may also be interested in...
Mooted some time ago, the Medicare Part D Drug Rebate Rule and the Medicare Part B Most-Favored-Nation Model have now been finalized by US President Donald Trump. But US off-patent body the Association for Accessible Medicines feels “further action is necessary.”
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.